Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03331276 · ClinicalTrials.gov registry record · NA
Growth and Safety Study of an Infant Formula for Healthy Term Infants
A NA study of Infant Development, sponsored by Building Block Nutritionals.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 6
- Study locations
NCT03331276: Completed NA study of Infant Development, sponsored by Building Block Nutritionals.
NCT03331276 is a NA study of Infant Development that has completed, run by Building Block Nutritionals. The registered enrollment target is 260 participants, below the 394-participant average among 30 other Infant Development trials with a reported enrollment target (34% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03331276, a NA study of Infant Development, has completed, sponsored by Building Block Nutritionals.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 6
- Study locations
Study Summary
A goal of infant formula development is to mimic human milk (HM) both in nutrient composition as well as physiologic outcomes. investigators have developed an infant formula for term infants that more closely resembles the composition of human milk. The purpose of this study is to demonstrate that this formulation meets nutritional requirements and supports age appropriate growth of healthy term infants.
Primary Outcome
g/d
Conditions Studied
Interventions
- OTHER BBN
- OTHER Brand
Study Locations (6)
Alabama
- Alabama Clinical Therapeutics - Birmingham
- Southeastern Pediatric Associates - Dothan
Tennessee
- HMG Pediatrics at Medical Plaza - Bristol
- Jackson Clinic - Jackson
Connecticut
- Norwich Pediatric Group - Norwich
Ohio
- Aventiv Research - Grove City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2019-01-07 |
| Phase | NA |
What the finished NCT03331276 record still lists
NCT03331276 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 394-participant average among 30 other Infant Development trials with a reported enrollment target (34% lower).
The record links to 1 condition, with Infant Development appearing as the primary indexed condition, and to 2 interventions - of which BBN is the first listed.
NCT03331276 lists 6 locations in 4 states (Alabama, Tennessee, Connecticut).
Frequently Asked Questions
What is clinical trial NCT03331276 about?
NCT03331276 is a clinical study titled "Growth and Safety Study of an Infant Formula for Healthy Term Infants". A goal of infant formula development is to mimic human milk (HM) both in nutrient composition as well as physiologic outcomes. investigators have developed an infant formula for term infants that more closely resembles the composition of human milk. The purpose of this study is to demonstrate that t...
What is the current status of trial NCT03331276?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2017-09-18. Estimated completion is 2019-01-07.
What conditions does trial NCT03331276 study?
This clinical trial studies the following conditions: Infant Development.
What interventions are being tested in trial NCT03331276?
The interventions under investigation include: BBN (OTHER), Brand (OTHER).
Who is sponsoring clinical trial NCT03331276?
This trial is sponsored by Building Block Nutritionals, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03331276 being conducted?
This trial has 6 study locations across Alabama, Connecticut, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant Development
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03331276's enrollment target sits among peer trials
260 7th of 30 higher than 24 of 30 other Infant Development trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infant Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Walnuts as an Infant Solid Food for Health
RECRUITING · NA
-
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
RECRUITING · NA
-
The Impact of Music Medicine on Preterm Brain Development and Behavior
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
Investigating Baby Behavior and Family Technology Use Study
RECRUITING · NA
-
Investigating Fit and Satisfaction of the Prone Positioner
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI